BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10190790)

  • 1. Paclitaxel in the treatment of esophageal cancer.
    Weiner LM
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.
    Kelsen D; Ginsberg R; Bains M; Cooper J; Arquette M; Forastiere AA; Ilson D
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-77-S19-81. PubMed ID: 9427272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review and outlook for the role of paclitaxel in urothelial carcinoma.
    Vaughn DJ
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
    Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
    Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of paclitaxel in the therapy of bladder cancer.
    Roth BJ
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):33-40. PubMed ID: 7481859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
    Greco FA; Hainsworth JD
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
    Hudis CA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel pharmacology and other tumor types.
    Rowinsky EK
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-12. PubMed ID: 9427257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel combination therapy in the treatment of metastatic breast cancer.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):29-39. PubMed ID: 8941408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel plus nonanthracycline combinations in metastatic breast cancer.
    Perez EA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):21-6. PubMed ID: 10190781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel: current developmental approaches of the National Cancer Institute.
    Arbuck SG
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.
    Seidman AD; Hudis CA; Fennelly D; Raptis G; Baselga J; Norton L
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):108-16. PubMed ID: 7481852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future developments for paclitaxel in the treatment of breast cancer.
    Bonadonna G
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):65-8. PubMed ID: 8629041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
    Hortobagyi GN; Holmes FA; Ibrahim N; Champlin R; Buzdar AU
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S30-3. PubMed ID: 9071338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.
    Buzdar AU; Hortobagyi GN; Asmar L; Theriault RL; Rahman Z; McNeese M; Singletary S; Ames F
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-31-S17-34. PubMed ID: 9374089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.